Fellowship Research

Current Fellow

Research Project: Regional Implementation of Pediatric CAP Guidelines
Research Mentors: Brenda Tesini, MD, Ghinwa Dumyati, MD, Lauren Camaione, PharmD, Anne Fallon, MD, Jennifer Nayak, MD

Development of Anti-microbial Agents for the Therapeutic Intervention of Multi-drug Resistant Bacteria

Perlmutter JI, Forbes LT, Krysan DJ, Ebsworth-Mojica K, Colquhoun JM, Wang JL, Dunman PM, Flaherty DP. Repurposing the Antihistamine Terfenadine for Antimicrobial Activity Against Staphylococcus Aureus. Journal of Medicinal Chemistry. 2014. 57(20), 8540-8562.
Forbes L, Ebsworth-Mojica K, DiDone L, Li S, Freundlich JS, Connell N, Dunman PM, Krysan DJ. A High Throughput Screening Assay for Anti-mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Death. PLOS One. May 14, 2015.

Role of Macrophage in Protection from Pneumocystis

Hoy Z, Dodds-Ashley ES, Weinberg GA, Krysan DJ. The Pediatric Infectious Diseases Consultant: Voriconazole Therapeutic Drug Monitoring. Journal of Pediatric Infectious Diseases Society. 2014 Sep; 3(3):270-1. Epub 2014 Mar 30.
Zhang ZQ, Wang J, Hoy Z, Keegan A, Bhagwat S, Gigliotti F, Wright TW. Neither Classical nor Alternative Macrophage Activation Is Required for Pneumocystis Clearance during Immune Reconstitution Inflammatory Syndrome Infection and immunity. Infection and Immunity. 2015 83(12):4594-603. Epub 2015 Sep 14.
Hoy Z and Tesini. Pneumocystosis. In Gamble, K.C., and M.M. Clancy (eds). Infectious Diseases of Concern to Captive and Free Ranging Animals in North America, 2^nd ed. 2013. Infectious Disease Committee, American Association of Zoo Veterinarians, Yulee, Florida. 1098 pp.

Clausen Fellowship Award, Strong Children's Research Center, University of Rochester Medical Center, 2013-2014.

Analysis of a Prototype Pneumocystis Vaccine

Warren HS, Fitting C, Hoff E, Abid-Conquy M, Beasley-Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, Cavaillon JM. Resilience to Bacterial Infection: Difference Between Species Could Be Due to Proteins in Serum. J Infect Dis. 2010 Jan 15; 201(2):223-32.
Liang M, Bagchi A, Warren HS, Tehan M, Trigilio J, Beasley-Topliffe L, Tesini B, Lazzaroni JC, Fenton M, Hellman J. Bacterial Peptidoglycan-Associated Lipoprotein: A Naturally Occurring Toll-Like Receptor 2 Agonist that is Shed into Serum and Had Synergy with Lipopolysaccharide. J Infect Dis. 2005 March; 191(6):939-48.
Tesini B, Epstein L and Caserta M. Clinical Impact of Primary Infection with Roseolovirsues. Curr Opin Virol. 2014 Dec 9; 91-6.
Hoy Z. and Tesini B. Pneumocystosis. In Gamble, K.C., and M.M. Clancy (eds). Infectious Diseases of Concern to Captive and Free Ranging Animals in North America, 2^nd ed. 2013. Infectious Disease Committee, American Association of Zoo Veterinarians, Yulee, Florida. 1098 pp.

Travel Award, NIAID/IDSA Infectious Diseases Research Careers Meeting, May 2014
Clausen Fellowship Award, Strong Children's Research Center, University of Rochester Medical Center, 2013-2014.
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases Fellows Program Award, American Society for Microbiology, Washington, DC, September 2014.